Gladstone Capital Corporation May 2017 At-the-Market Program

We represented Gladstone Capital Corporation in its offering of up to $50,000,000 aggregate of shares of common stock in connection with an at-the-market program.

Gladstone Capital Corporation (NASDAQ:GLAD) is a publicly traded business development company that invests in debt and equity securities, consisting primarily of senior term loans, second term lien loans, and senior subordinated term loans in small and medium sized businesses in the United States.

You Also May Be Interested In:

  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company